<DOC>
	<DOCNO>NCT01150500</DOCNO>
	<brief_summary>The objective study To verify safety efficacy MDT-4107 Drug-Eluting Coronary Stent treatment de novo lesion native coronary artery reference vessel diameter ( RVD ) allow use 2.25mm diameter stent .</brief_summary>
	<brief_title>RESOLUTE Japan SVS : The Clinical Evaluation MDT-4107 DES Treatment De Novo Lesions Small Diameter Native Coronary Arteries</brief_title>
	<detailed_description>The objective study verify safety efficacy MDT-4107 Drug-Eluting Coronary Stent treatment de novo lesion native coronary artery reference vessel diameter ( RVD ) allow use 2.25mm diameter stent .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Acceptable candidate percutaneous coronary intervention ( PCI ) , stenting , emergency coronary artery bypass graft surgery Clinical evidence ischemic heart disease , stable unstable angina , silent ischemia and/or positive functional study Informed consent Patient agree comply specify followup evaluation investigational site Single target lesion two target lesion locate separate coronary artery De novo lesion ( ) native coronary artery ( y ) Target lesion ( ) ≤ 27 mm length Target vessel ( ) reference vessel diameter 2.25 mm 3.5 mm Within 7 day implant platelet count &lt; 100,000 cells/mm³ &gt; 700,000 cells/mm³ ; White Blood Cell ( wbc ) count &lt; 3,000 cells/mm³ ; serum creatinine level &gt; 2.5 mg/dl Acute myocardial infarction ( MI ) within 72 hrs index procedure ( Q wave myocardial infarction ( QWMI ) /non Q wave myocardial infarction ( NQMI ) elevation creatinine kinease myocardialband isoenzyme ( CKMB ) &gt; lab upper limit normal ) Previous PCI target vessel ( ) within 9 month prior procedure Planned PCI vessel within 30 day postindex procedure and/or plan PCI target vessel ( ) within 12 month postindex procedure History stroke transient ischemic attack ( TIA ) within prior 6 month Participating investigational drug/device study complete primary endpoint interferes study endpoint Inability comply require trial antiplatelet regimen Previous stent target vessel unless least 9 month since stent place target lesion ( ) is/are least 15 mm previous stent Target vessel ( ) has/have lesion w/ &gt; 40 % diameter stenosis Unprotected leave main coronary artery disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Medtronic</keyword>
	<keyword>Japan</keyword>
	<keyword>Arterial Occlusive Diseases</keyword>
	<keyword>Myocardial Ischemia</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Small Vessel Stent</keyword>
</DOC>